Progyny
Progyny, Inc. is an American healthcare benefit management company specializing in fertility and family-building benefit solutions for employers. The company offers comprehensive fertility benefits coverage, including assisted reproductive technology, in vitro fertilization, egg freezing, surrogacy, adoption support, and personalized clinical care management. Revenue is generated primarily from per-employee subscription fees charged to corporate plan sponsors and utilization-based pharmacy benefit management fees under the Progyny Rx program. Progyny serves self-insured corporate employers, enterprise organizations, and private health plans across the United States. The enterprise commands a market-leading position as a specialized provider of corporate fertility and family-building benefits management. Progyny, Inc. is headquartered in New York, New York, United States, and its common stock is listed on the Nasdaq Global Select Market.
8 of the funds FundTelligence covers report a position in Progyny.
- Legal name
- Progyny Inc.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 8
- Exposure themes
- Reproductive health, Treatment, Women's Health
Funds holding Progyny
- DNB Fund Women's Health — DNB · 2.23 % (full portfolio disclosed, August 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.23 % (full portfolio disclosed, December 2025)
- KLP AksjeGlobal Small Cap Flerfaktor — KLP · 0.15 % (full portfolio disclosed, June 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.14 % (full portfolio disclosed, September 2026)
- DNB Global Enhanced Small Cap — DNB · 0.03 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- Nordea Internationale aktier — Nordea Funds · 0.01 % (full portfolio disclosed, September 2026)